COVID-19 Research with Mass Cytometry High-dimensional immune profiling | Thaddaeus Teo, MID
17 June 2020
COVID-19 Research with Mass Cytometry (High-dimensional immune profiling)
Thaddaeus Teo, MID, CyTOF® Application Scientist, Fluidigm
Abstract:
Crucial questions about how SARS-CoV-2 affects our immune system and how to monitor the response to newly developed therapeutic interventions must be answered, and quickly.
In this webinar:
1. Learn how CyTOF® technology enables Immune monitoring with the cost, flexibility, and consistency needed for COVID-19 immune monitoring research.
2. Discover more about the Maxpar® Direct™ Immune Profiling System, a single-tube format and software solution that works with either whole blood or PBMC samples and find out how to customise and expand the panel.
3. Hear about how mass cytometry is used in multi-site studies, clinical trials and projects currently being carried out all over the world.